

Transforming Precision Medicine Through Magnetic Nanoparticle Technology
Advanced molecular diagnostics using proprietary magnetic nanoparticle technology to isolate exosomes, DNA, RNA, lncRNA, fusion genes, and biomarkers for early disease detection.
Our Technology Workflow
Urine Sample Collection
Magnetic Nanoparticle Capture
Simultaneous Biomarker Isolation
qPCR & Sequencing Analysis
Non-invasive collection of clinical urine samples for biomarker analysis.
Downstream molecular analysis for precise biomarker quantification.
Proprietary MNPs selectively bind to target exosomes and nucleic acids.
Integrated workflow for co-extraction of DNA, RNA, and fusion genes.








Key Research Areas
Prostate Cancer Diagnostics
Early detection through highly sensitive urinary exosomal biomarkers, enhancing clinical outcomes.
Fusion Gene Detection
Sensitive identification of clinically relevant fusion transcripts for targeted therapies and research.
lncRNA Biomarker Discovery
Novel epigenetic biomarkers for cancer diagnosis and prognosis using advanced transcriptomic analysis.
Precision Oncology
Personalized molecular diagnostics powered by nanotechnology, guiding future precision medicine strategies.
Consolidating exosome isolation and nucleic acid extraction to eliminate variance in clinical trials.
Our zero-loss extraction workflows ensure consistent, reliable results, critical for the integrity of translational oncology research and diagnostic development.
SCB-Tech
Proprietary magnetic nanoparticle platforms for simultaneous multi-marker capture.
EXPLORE
Home
Products
Technology
Services
Tutorials
About
SCIENTIFIC SUPPORT
Tanshulin@scb-tech.net
Huangpu District, Guangzhou, China
SCB-Tech Research Laboratory
© 2026 SCB-Tech-Proprietary magnetic nanoparticle technology for translational oncology.
PRECISION MOLECULAR DIAGNOSTICS
